Skip to main content
The Markets by Proactive
Go to Proactive Australia

Pharma & Biotech

IQ-AI starts trading on US OTC market

The listing will provide more efficient access to a new and materially larger pool of prospective US investors

IQ-AI Ltd (LSE:IQAI, FRA:5Y1) (LSE:IQAI) shares will begin trading on the OTCQB Venture Market in the United States from today under the ticker symbol "IQAIF".

In a statement, the neuroimaging data specialist said its objective in listing its shares on the OTCQB is to provide more efficient access to a new and materially larger pool of prospective US investors.

Trevor Brown, chief executive, added: "The United States is home to some of the world's most influential medical technology investors.

“By joining OTCQB, we now have an effective platform from which to reach a significantly larger investor audience and we look forward to providing investors in both the UK and the United States with regular progress updates at this exciting and pivotal time for the company."